共 50 条
- [1] Molecular Pathology of Urothelial Carcinoma [J]. CLINICS IN LABORATORY MEDICINE, 2024, 44 (02) : 181 - 198
- [4] Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma [J]. RESEARCH AND REPORTS IN UROLOGY, 2018, 10 : 251 - 261
- [5] Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 2505 - 2512
- [7] Colorectal carcinoma as an example of molecular cancer predisposition diagnosis - What can pathology contribute? [J]. PATHOLOGE, 1998, 19 (04): : 269 - 278
- [8] Next Generation Digital Pathology: Emerging Trends and Measurement Challenges for Molecular Pathology [J]. JOURNAL OF MOLECULAR PATHOLOGY, 2022, 3 (03): : 168 - 181
- [9] Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use [J]. NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (12): : 676 - 685
- [10] Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use [J]. Nature Clinical Practice Urology, 2008, 5 : 676 - 685